clinicaltrials.gov 5-amino-1mq Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic Selective and membrane-permeable small molecule

Folic acid when taken in a larger dose for a prolonged duration can impair the therapeutic response of Mecobalamin

In clinical trials common side effects included: Nausea, vomiting Diarrhoea, constipation Low blood sugar (when used with certain diabetes medications) Loss of appetite, indigestion, abdominal pain Dizziness, low blood pressure, tiredness Allergic reactions Serious side effects include: Pancreatitis (inflamed pancreas) Gallstones Gastroparesis Hypoglycemia (very low sugar levels) If you experience any serious side effects, you should contact NHS 111

The emphasis of this page is therefore on catalog clarity, research-only designation, and practical logistics rather than any claim regarding biological application or outcome

To learn more about the benefits, risks, & differences of compounded medication substitutes you may visit the FDA Drug Shortage List & FDA Compounding Substitutions Information Page